LIG48 is an inhibitor of the ROS1 kinase domain and its mutant form (G2032R ROS1 kinase domain). It effectively inhibits both mutant and wild-type ROS1 kinase domains and is applicable to non-small cell lung cancer research.
Target:
ROS Kinase
* VAT and and shipping costs not included. Errors and price changes excepted
